Margin note
Acquired does not mean bought.
Three filings land in EDGAR the same morning. A director receives a scheduled restricted-stock grant. A CEO exercises vested options. A CFO uses personal cash to buy shares in the open market. A screen aggregates all three under one headline: insider buying.
The label is generous. A disciplined analyst wants to know what each person actually gave up.
Form 4s are useful because they are mandatory, arrive quickly, and may be the only fresh ownership event for months in a neglected company. A personal open-market purchase does not require a press release or create a Regulation FD obligation — that rule governs selective disclosure by the issuer to market professionals, and an insider's own purchase is simply a routine EDGAR filing. It appears in the system, mixed among grants, exercises, planned transactions, and administrative debris.
"Acquired" does not necessarily mean "bought." Compensation has a habit of arriving dressed as conviction.
Start With the Transaction
Section 16 covers directors, officers, and beneficial owners of more than 10% of a class. Form 3 establishes the initial position, generally within ten days of becoming an insider. Form 4 reports covered transactions within two business days of the trade date — a hard deadline with no grace period, and lateness is disclosed in the company's proxy. Form 5 handles certain transactions reported annually.
That machinery shows when ownership changed, and nothing at all about why.
The trade date and filing date also describe different moments. A Monday purchase reported Wednesday is Monday's decision, not a fresh opinion formed Wednesday morning. In a heavily followed stock, that distinction barely survives contact with the market. In a micro-cap with no analyst waiting for the filing, there may be no natural buyer assigned to notice.
So reconstruct the event. What security changed hands? Was cash paid? Was the transaction discretionary? Did total exposure rise? Three directors receiving identical grants on the same date usually reflects one compensation decision, not three independent conclusions about valuation.
The Sieve
Run every reported acquisition through five questions before it gets anywhere near an order.
First, what is the economic transaction?
Open-market purchases, equity grants, option exercises, compensation-driven acquisitions, 10b5-1 transactions, and administrative transfers can all appear on the same form. They do not carry the same information. What matters is the insider choosing to increase exposure, not merely receiving what the compensation committee already approved.
Second, how much personal capital is at risk?
Cash paid in an open-market purchase is the cleanest evidence of discretionary intent. A transaction under a 10b5-1 plan may still reflect a prior decision, but the relevant discretion was exercised when the plan was adopted, not necessarily on the reported trade date. A modest purchase made with personal funds can say more than a much larger grant.
Third, is the amount meaningful?
The dollar figure needs denominators: compensation, existing ownership, previous awards, and transaction history. There is no universal threshold. A small purchase may be a cheap gesture designed to be noticed. A meaningful one leaves the insider materially more exposed to being wrong.
Fourth, is this a transaction or a pattern?
Use Form 3 as the opening balance and turn subsequent Form 4s into a ledger: trade date, filing date, transaction type, cash committed, shares held afterward, and whether a plan was involved. Then strip away grants and mechanical exercises to see whether net exposure is actually rising.
An annual award followed by routine sales is compensation administration. Repeated purchases that increase an already meaningful stake deserve more work.
Fifth, who is buying?
A senior operating executive using personal cash generally deserves more attention than a director making a token purchase. Proximity to the business raises the signal's potential value, but it also raises the standard of proof. Incentives, compensation, liquidity needs, and prior behavior still have to be understood.
After that work, the filing becomes less exciting and more useful.
What the Historical Evidence Says
The evidence is asymmetric. Insider sales can reflect taxes, diversification, or personal spending. Purchases have fewer routine explanations.
Lakonishok and Lee, studying insider trades from 1975 through 1995, found that predictive power was concentrated in small, less-followed firms. Insider purchases in small-cap companies were associated with something on the order of 7% abnormal returns over the following twelve months. Jeng, Metrick, and Zeckhauser later found that insider-purchase portfolios earned abnormal returns exceeding roughly six percentage points annually, while insider sales showed no significant abnormal return.
Those are historical sample results, largely from before 2000, specific to their samples and windows. They are not expected returns for the next Form 4 that appears in EDGAR, and they do not rescue a weak business or an expensive stock.
What they establish is narrower: insider purchases have historically carried more information than sales, with the effect strongest where outside attention is scarce. That indicates where ledger work may be worth the hour.
A Useful Signal With Very Little Capacity
The setup worth wanting is deliberately inconvenient: a current reporting issuer, a senior insider spending personal cash on an open-market purchase, a material increase in an existing stake, little outside coverage, and enough liquidity for a small position but not enough for institutional size.
The capacity limit is part of the signal's survival.
A fund cannot extract much value from an opportunity that only supports a position too small to affect its portfolio. If it buys enough shares to matter, it can move the price and surrender the edge through spread and impact. Research on post-earnings-announcement drift shows the same liquidity gradient, and the magnitudes are worth reading as illustration rather than as a promised spread: in one study's extreme deciles, the strategy returned roughly 0.04% a month among the most liquid stocks against about 2.43% a month among the most illiquid — while transaction costs consumed somewhere between 70% and 100% of the paper profit.
The anomaly persists where harvesting it is expensive.
Before acting, check the spread, effective float, median and average daily volume, and the insider's purchase relative to normal trading flow. Estimate how many days entry might take, then perform the less cheerful calculation for the exit. If the stock trades OTC, check its SEC filing history and quotation status separately from the venue label. An issuer that stops making current public information available can lose eligibility for a published public quotation under Rule 15c2-11 and become materially harder to trade, which turns a slow exit into no exit without anyone announcing it.
A clean insider purchase cannot compensate for disappearing disclosure.
The Final Check
Reduce the filing to a short list:
- Was it an open-market purchase made with personal funds?
- Was it discretionary rather than compensation or a previously arranged plan transaction?
- Is the size meaningful relative to compensation and existing ownership?
- Is total exposure rising across multiple filings?
- Is the issuer current in its reporting?
- Can a position be entered and exited without spending the expected edge on spread and impact?
Then underwrite the company. The balance sheet, valuation, dilution risk, governance, and operating results still have to work. Form 4 activity merely indicates where informed capital may be moving before anyone bothers to narrate it.
The ledger has an obvious hole in it, and the discipline above does nothing to close it. It records what an insider did and never what they knew, and an officer who is confidently, expensively wrong about their own company files on exactly the same form as one who is right. The filter separates compensation from conviction. It has no opinion whatsoever about whether the conviction is any good.
Return to the three filings. The grant costs the director no purchase price. The option exercise may reflect compensation mechanics rather than a new view. The CFO's open-market purchase commits personal capital, but even that earns only a place in the ledger.
The useful question is whether ownership is building through deliberate purchases — or whether a routine allocation happened to arrive on a form carrying the word "insider."
